ANTIPODES PARTNERS LTD – Gilead Sciences, Inc. Transaction History
ANTIPODES PARTNERS LTD portfolio value:
$65.81M
portfolio value
Gilead Sciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | 0.00% | 1.06M shares | 65.81M | $61.69 | 1.06M |
| Q4 2020 | share | Decrease | -100.00% | -355.41K shares | -22.45M | $56.43 | 0 |
| Q3 2020 | share | Decrease | -60.41% | -542.43K shares | -46.62M | $60.52 | 355.41K |
| Q2 2020 | share | Increase | +0.84% | 7.47K shares | 2.51M | $72.94 | 897.84K |
| Q1 2020 | share | Decrease | -41.00% | -618.72K shares | -31.49M | $70.22 | 890.36K |
| Q4 2019 | share | Decrease | -17.28% | -315.19K shares | -17.56M | $60.43 | 1.50M |
| Q3 2019 | share | Decrease | -2.65% | -49.71K shares | -10.98M | $58.4 | 1.82M |
| Q2 2019 | share | Increase | +34.34% | 479.03K shares | 35.92M | $61.67 | 1.87M |
| Q1 2019 | share | Decrease | -17.94% | -304.95K shares | -15.64M | $58.79 | 1.39M |
| Q4 2018 | share | Decrease | -11.40% | -218.78K shares | -41.81M | $56.02 | 1.69M |
| Q3 2018 | share | Decrease | -7.69% | -159.84K shares | 900K | $68.57 | 1.91M |
| Q2 2018 | share | Decrease | -23.18% | -627.29K shares | -56.75M | $62.43 | 2.07M |
| Q1 2018 | share | Increase | +50.62% | 909.37K shares | 75.29M | $65.91 | 2.70M |
| Q4 2017 | share | Increase | +40.61% | 518.89K shares | 25.28M | $62.19 | 1.79M |
| Q3 2017 | share | Increase | +16.64% | 182.23K shares | 25.89M | $69.84 | 1.27M |
| Q2 2017 | share | Increase | +40.18% | 313.93K shares | 21.9M | $60.63 | 1.09M |
| Q1 2017 | share | Increase | +23.41% | 148.22K shares | 10.06M | $57.72 | 781.41K |
| Q4 2016 | share | Increase | 0.00% | 633.19K shares | 45.56M | $60.39 | 633.19K |